Cargando…
Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy
Chronic heart failure (CHF) is a major contributor to cardiovascular disease and is the leading cause of hospitalization for those over the age of 65, which is estimated to account for close to seventy billion dollars in healthcare costs by 2030 in the US alone. The successful therapies for preventi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979534/ https://www.ncbi.nlm.nih.gov/pubmed/29621141 http://dx.doi.org/10.3390/ijms19041086 |